Skip to main content

Yeaman Kevin J's Form 4 filing

Dolby Laboratories, Inc. (DLB) · filed Oct 17, 2024

Accession no.
0000950170-24-115380
Filed
Oct 17, 2024
Trade date
Oct 15, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.11M. It was filed 2 days after the trade.

This filing was later replaced by the amendment 0000950170-24-120226 (Nov 1, 2024). Trade tables on this site use the amended version.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Yeaman Kevin JCIK 0001200469Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 15, 2024Class A Common StockMOption exerciseAcquired+28,512$62.32+$1,776,867.84112,233Indirect
Oct 15, 2024Class A Common StockSSaleDisposed−18,696$73.90F3−$1,381,634.493,537Indirect
Oct 15, 2024Class A Common StockSSaleDisposed−9,816$74.55F4−$731,782.883,721Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 15, 2024Class A Common StockMOption exerciseDisposed−28,512$0.00$057,888Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

The shares were sold in multiple transactions at prices ranging from $73.38 to $74.375, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

F4

The shares were sold in multiple transactions at prices ranging from $74.38 to $74.74, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

Referenced by the price of 1 transaction in Table I.

Remarks

All of the transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Read the full filing on SEC EDGAR (opens in a new tab)